6.18
-0.15 (-2.37%)
Penutupan Terdahulu | 6.33 |
Buka | 6.23 |
Jumlah Dagangan | 5,213 |
Purata Dagangan (3B) | 80,096 |
Modal Pasaran | 536,325,696 |
Harga / Jualan (P/S) | 2.67 |
Harga / Buku (P/B) | 2.87 |
Julat 52 Minggu | |
Tarikh Pendapatan | 12 Aug 2025 |
Margin Keuntungan | -7.22% |
Margin Operasi (TTM) | -38.61% |
EPS Cair (TTM) | -0.180 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 26.40% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 119.34% |
Nisbah Semasa (MRQ) | 2.61 |
Aliran Tunai Operasi (OCF TTM) | -67.22 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -83.02 M |
Pulangan Atas Aset (ROA TTM) | -10.03% |
Pulangan Atas Ekuiti (ROE TTM) | -7.91% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Biotechnology (US) | Menurun | Menurun |
Biotechnology (Global) | Menurun | Menurun | |
Stok | Valneva SE | Menurun | Menurun |
AISkor Stockmoo
Konsensus Penganalisis | 3.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -2.0 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | -0.5 |
Purata | 0.13 |
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales. |
|
Sektor | Healthcare |
Industri | Biotechnology |
Gaya Pelaburan | Small Core |
% Dimiliki oleh Institusi | 0.87% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
General American Investors Co Inc | 31 Dec 2024 | 354,361 |
Ironwood Investment Management Llc | 31 Dec 2024 | 25,022 |
Vsm Wealth Advisory, Llc | 31 Dec 2024 | 1,000 |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 17.00 (HC Wainwright & Co., 175.08%) | Beli |
Median | 15.50 (150.81%) | |
Rendah | 14.00 (Guggenheim, 126.54%) | Beli |
Purata | 15.50 (150.81%) | |
Jumlah | 2 Beli | |
Harga Purata @ Panggilan | 6.72 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Guggenheim | 08 May 2025 | 14.00 (126.54%) | Beli | 6.38 |
24 Mar 2025 | 15.00 (142.72%) | Beli | 7.43 | |
HC Wainwright & Co. | 15 Apr 2025 | 17.00 (175.08%) | Beli | 7.05 |
09 Apr 2025 | 17.00 (175.08%) | Beli | 6.77 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |